UMB Financial (UMBF) Touches $76.08 Formed H&S; Orbimed Advisors Upped Its Cigna (CI) Position

UMB Financial Corporation (UMBF) formed inverse H&S with $80.64 target or 6.00% above today’s $76.08 share price. UMB Financial Corporation (UMBF) has $3.79B valuation. The stock increased 0.33% or $0.25 during the last trading session, reaching $76.08. About 111,893 shares traded. UMB Financial Corporation (NASDAQ:UMBF) has risen 26.44% since January 15, 2017 and is uptrending. It has outperformed by 9.74% the S&P500.

Orbimed Advisors Llc increased Cigna Corporation (CI) stake by 3.6% reported in 2017Q3 SEC filing. Orbimed Advisors Llc acquired 44,000 shares as Cigna Corporation (CI)’s stock rose 11.09%. The Orbimed Advisors Llc holds 1.27 million shares with $236.69M value, up from 1.22M last quarter. Cigna Corporation now has $52.61B valuation. The stock increased 1.19% or $2.5 during the last trading session, reaching $213.39. About 1.15 million shares traded. Cigna Corporation (NYSE:CI) has risen 23.57% since January 15, 2017 and is uptrending. It has outperformed by 6.87% the S&P500.

Among 19 analysts covering CIGNA (NYSE:CI), 15 have Buy rating, 0 Sell and 4 Hold. Therefore 79% are positive. CIGNA had 54 analyst reports since July 27, 2015 according to SRatingsIntel. The firm has “Overweight” rating given on Monday, August 7 by Morgan Stanley. The stock of Cigna Corporation (NYSE:CI) earned “Buy” rating by Citigroup on Friday, November 3. Barclays Capital maintained Cigna Corporation (NYSE:CI) on Wednesday, January 6 with “Equal-Weight” rating. The rating was maintained by Jefferies on Thursday, November 2 with “Buy”. The firm earned “Buy” rating on Thursday, July 13 by Cowen & Co. RBC Capital Markets maintained Cigna Corporation (NYSE:CI) on Friday, November 3 with “Buy” rating. As per Wednesday, January 3, the company rating was initiated by Goldman Sachs. On Friday, January 12 the stock rating was maintained by Jefferies with “Buy”. The stock of Cigna Corporation (NYSE:CI) has “Overweight” rating given on Wednesday, January 4 by Piper Jaffray. The stock of Cigna Corporation (NYSE:CI) has “Buy” rating given on Monday, August 7 by Deutsche Bank.

Orbimed Advisors Llc decreased Aerie Pharmaceuticals Inc (NASDAQ:AERI) stake by 393,465 shares to 1.44 million valued at $69.90M in 2017Q3. It also reduced Incyte Corp (Put) (NASDAQ:INCY) stake by 1.46 million shares and now owns 200,000 shares. Newlink Genetics Corp (NASDAQ:NLNK) was reduced too.

Since August 7, 2017, it had 0 buys, and 9 selling transactions for $13.93 million activity. Sadler Jason D had sold 37,756 shares worth $6.65 million. Another trade for 28,037 shares valued at $5.77M was made by MURABITO JOHN M on Wednesday, January 10. $43,604 worth of stock was sold by ZOLLARS WILLIAM D on Wednesday, January 10. Shares for $45,762 were sold by HARRIS ISAIAH JR. Bacus Lisa R sold $402,366 worth of Cigna Corporation (NYSE:CI) on Wednesday, August 16. 3,700 shares were sold by Triplett Michael W, worth $647,360 on Tuesday, August 8. The insider Hoeltzel Mary T sold $93,232.

Investors sentiment is 0.96 in 2017 Q3. Its the same as in 2017Q2. It is without change, as 47 investors sold CI shares while 249 reduced holdings. only 72 funds opened positions while 212 raised stakes. 206.32 million shares or 5.35% less from 217.98 million shares in 2017Q2 were reported. Great Lakes Limited Liability Company holds 0.1% or 23,695 shares in its portfolio. Monetary Mngmt Gp Inc owns 2,950 shares. Royal Fincl Bank Of Canada reported 0.03% of its portfolio in Cigna Corporation (NYSE:CI). Fjarde Ap holds 60,930 shares. Tarbox Family Office reported 144 shares or 0.01% of all its holdings. Bancshares Of Stockton reported 7,888 shares or 0.67% of all its holdings. Geode Cap Mngmt Lc invested in 2.38M shares or 0.16% of the stock. Nikko Asset Management Americas reported 0.01% stake. Johnson Financial Grp Inc reported 1,373 shares. Salem Counselors Incorporated reported 190 shares. Neuberger Berman Gp has invested 0.05% in Cigna Corporation (NYSE:CI). E&G Limited Partnership accumulated 1,100 shares. Cetera Advsrs Lc accumulated 8,084 shares. Marietta Inv Prns Limited Liability Company invested in 1.77% or 31,521 shares. Twin Cap Mngmt holds 0.04% of its portfolio in Cigna Corporation (NYSE:CI) for 3,591 shares.

Investors sentiment decreased to 1.04 in 2017 Q3. Its down 0.17, from 1.21 in 2017Q2. It dropped, as 17 investors sold UMB Financial Corporation shares while 55 reduced holdings. 11 funds opened positions while 64 raised stakes. 40.30 million shares or 0.01% less from 40.31 million shares in 2017Q2 were reported. Meritage Portfolio has 0.22% invested in UMB Financial Corporation (NASDAQ:UMBF). Proshare Advsr Ltd stated it has 0.17% of its portfolio in UMB Financial Corporation (NASDAQ:UMBF). Missouri-based American Century Cos has invested 0.08% in UMB Financial Corporation (NASDAQ:UMBF). Fisher Asset Mngmt Limited Liability Corporation has invested 0.07% in UMB Financial Corporation (NASDAQ:UMBF). Credit Suisse Ag accumulated 60,936 shares or 0% of the stock. Geode Cap Lc stated it has 0.01% of its portfolio in UMB Financial Corporation (NASDAQ:UMBF). Blackrock Inc invested in 4.74 million shares. Deprince Race And Zollo Incorporated has invested 0.61% in UMB Financial Corporation (NASDAQ:UMBF). Fmr Limited Liability Com holds 0.03% or 3.46M shares. Eagle Asset reported 778,457 shares. Parametric Assocs Ltd Liability Corporation holds 47,602 shares or 0% of its portfolio. 70,800 are owned by Swiss National Bank & Trust. Paloma Ptnrs Mngmt stated it has 0% of its portfolio in UMB Financial Corporation (NASDAQ:UMBF). Bnp Paribas Arbitrage Sa accumulated 0% or 23,523 shares. Citigroup has 0% invested in UMB Financial Corporation (NASDAQ:UMBF) for 143 shares.

Since December 13, 2017, it had 0 insider purchases, and 1 sale for $136,854 activity. 1,862 shares valued at $136,854 were sold by Swett Christian R on Wednesday, December 13.

Analysts await UMB Financial Corporation (NASDAQ:UMBF) to report earnings on January, 23. They expect $0.92 EPS, up 1.10% or $0.01 from last year’s $0.91 per share. UMBF’s profit will be $45.88 million for 20.67 P/E if the $0.92 EPS becomes a reality. After $0.98 actual EPS reported by UMB Financial Corporation for the previous quarter, Wall Street now forecasts -6.12% negative EPS growth.